Page last updated: 2024-11-06

thyroxine and Hyperlipoproteinemias

thyroxine has been researched along with Hyperlipoproteinemias in 6 studies

Thyroxine: The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.
thyroxine : An iodothyronine compound having iodo substituents at the 3-, 3'-, 5- and 5'-positions.

Hyperlipoproteinemias: Conditions with abnormally elevated levels of LIPOPROTEINS in the blood. They may be inherited, acquired, primary, or secondary. Hyperlipoproteinemias are classified according to the pattern of lipoproteins on electrophoresis or ultracentrifugation.

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19903 (50.00)18.7374
1990's3 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dobiásová, M1
Vondra, K1
Matousek, V1
Válek, J1
Weisweiler, P1
Schwandt, P1
Davignon, J1
Bogner, U1
Arntz, HR1
Peters, H1
Schleusener, H1
Glueck, CJ1
Lang, J1
Tracy, T1
Speirs, J1
Wallace, RB1
Pomrehn, P1
Heiss, G1
Chambless, LE1
Johnson, N1
Patten, R1
Lippel, K1
Rifkind, BM1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
[NCT00005128]0 participants Observational1972-07-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

1 review available for thyroxine and Hyperlipoproteinemias

ArticleYear
Prospects for drug therapy for hyperlipoproteinaemia.
    Diabete & metabolisme, 1995, Volume: 21, Issue:2

    Topics: Animals; Cholesterol; Forecasting; Humans; Hyperlipoproteinemias; Intestinal Absorption; Molecular S

1995

Other Studies

5 other studies available for thyroxine and Hyperlipoproteinemias

ArticleYear
Rate of LCAT-mediated cholesterol esterification and serum lipids during etiroxate therapy in hyperlipoproteinemia.
    Atherosclerosis, 1982, Volume: 42, Issue:2-3

    Topics: Body Weight; Cholesterol; Cholesterol Esters; Female; Humans; Hyperlipoproteinemias; Lipids; Lipopro

1982
[Lipoproteins and hyperlipoproteinemias].
    Fortschritte der Medizin, 1980, Mar-06, Volume: 98, Issue:9

    Topics: Blood Protein Disorders; Cholesterol; Cholestyramine Resin; Clofibrate; Diet Therapy; Humans; Hyperl

1980
Subclinical hypothyroidism and hyperlipoproteinaemia: indiscriminate L-thyroxine treatment not justified.
    Acta endocrinologica, 1993, Volume: 128, Issue:3

    Topics: Adolescent; Adult; Age Factors; Aged; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Female; Human

1993
The common finding of covert hypothyroidism at initial clinical evaluation for hyperlipoproteinemia.
    Clinica chimica acta; international journal of clinical chemistry, 1991, Sep-14, Volume: 201, Issue:1-2

    Topics: Adult; Aged; Cholesterol, LDL; Diagnosis, Differential; Evaluation Studies as Topic; Female; Humans;

1991
Alterations in clinical chemistry levels associated with the dyslipoproteinemias. The Lipid Research Clinics Program Prevalence Study.
    Circulation, 1986, Volume: 73, Issue:1 Pt 2

    Topics: Adult; Blood Glucose; Creatinine; Diabetes Mellitus; Dysgammaglobulinemia; Female; Humans; Hyperlipo

1986